Floatz logo

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT

Chronic Myeloid Leukemia

Fred Hutchinson Cancer Centerother_biologicalPhase 2/3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
65/ 100
Competitive Position
81/ 100

Competitive context

77 Active assets in the Chronic Myeloid Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 3BBB
Nilotinib
Novartis Pharmaceuticals
Phase 4BBB
Therapeutic Allogeneic Lymphocytes
University of Chicago
Phase 2BBB
Romidepsin
Center for International Blood and Marrow Transplant Research
Phase 2BBB
METHOTREXATE
M.D. Anderson Cancer Center
Phase 3BBB

View all 50 →

Same molecule, other indications

ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT is also rated in:

myelodysplastic/myeloproliferative neoplasmActive
BBB
Indicative · Phase 2/3
75 / 100
View asset →
plasma cell myelomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →
myeloproliferative neoplasmActive
BB
Indicative · Phase 2/3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →